Nagamitsu Clinic

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Migraine4 trials

Phase

• Phase 34 trials

Status

• Completed4 trials

Lead sponsor

• Pfizer2 trials
• Amgen1 trial
• H. Lundbeck A/S1 trial

Closed trials

• Completed

  Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

  NCT05399459· Phase 3· Pfizer· Source

• Completed

  Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

  NCT05399485· Phase 3· Pfizer· Source

• Completed

  Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan

  NCT05064371· Phase 3· H. Lundbeck A/S· Source

• Completed

  Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine

  NCT03832998· Phase 3· Amgen· Source